Ixabepilone‐induced mitochondria and sensory axon loss in breast cancer patients

Author:

Ebenezer Gigi J.1,Carlson Karen2,Donovan Diana2,Cobham Marta2,Chuang Ellen2,Moore Anne2,Cigler Tessa2,Ward Maureen2,Lane Maureen E.2,Ramnarain Anita2,Vahdat Linda T.2,Polydefkis Michael1

Affiliation:

1. Neurology Johns Hopkins University Baltimore Maryland

2. Breast Cancer Research Program Weill Cornell Medical College New York City New York

Funder

Bristol Myers Squibb Oncology

Anne Moore Breast Cancer Research Fund

Publisher

Wiley

Subject

Neurology (clinical),General Neuroscience

Reference51 articles.

1. Cancer Statistics, 2005

2. Use of Imputed Population-based Cancer Registry Data as a Method of Accounting for Missing Information: Application to Estrogen Receptor Status for Breast Cancer

3. Promotion of microtubule assembly in vitro by taxol

4. Phase I trial of sequential high‐dose chemotherapy with escalating dose paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer;Vahdat LT;Clin Cancer Res,1998

5. Efficacy and Safety of Ixabepilone (BMS-247550) in a Phase II Study of Patients With Advanced Breast Cancer Resistant to an Anthracycline, a Taxane, and Capecitabine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3